Astera Labs (NASDAQ:ALAB) Price Target Raised to $200.00

Astera Labs (NASDAQ:ALAB) had its target price raised by Stifel Nicolaus from $185.00 to $200.00 in a report released on Wednesday morning, Marketbeat Ratings reports. They currently have a buy rating on the stock.

Other equities research analysts have also issued research reports about the company. Deutsche Bank Aktiengesellschaft increased their price target on Astera Labs from $160.00 to $200.00 and gave the company a “buy” rating in a research report on Tuesday, September 2nd. Bank of America started coverage on shares of Astera Labs in a report on Friday, October 3rd. They issued a “neutral” rating and a $230.00 target price on the stock. Weiss Ratings reiterated a “hold (c-)” rating on shares of Astera Labs in a research note on Wednesday, October 8th. Zacks Research cut shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 6th. Finally, Wall Street Zen upgraded shares of Astera Labs from a “hold” rating to a “buy” rating in a report on Monday, November 3rd. Thirteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $181.59.

Astera Labs Stock Up 1.6%

Astera Labs stock opened at $165.49 on Wednesday. The company’s 50 day moving average is $195.98 and its two-hundred day moving average is $139.94. The firm has a market cap of $27.95 billion, a PE ratio of 149.09, a price-to-earnings-growth ratio of 3.62 and a beta of 1.37. Astera Labs has a 52-week low of $47.13 and a 52-week high of $262.90.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.10. The business had revenue of $230.58 million for the quarter, compared to analyst estimates of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The company’s revenue was up 103.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.23 earnings per share. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, equities research analysts anticipate that Astera Labs will post 0.34 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, COO Sanjay Gajendra sold 91,441 shares of the stock in a transaction on Monday, August 18th. The shares were sold at an average price of $183.51, for a total value of $16,780,337.91. Following the transaction, the chief operating officer directly owned 2,170,877 shares of the company’s stock, valued at $398,377,638.27. This trade represents a 4.04% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the sale, the director owned 385,863 shares in the company, valued at $66,858,482.01. This represents a 32.17% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 534,480 shares of company stock worth $97,000,380. 12.50% of the stock is currently owned by company insiders.

Institutional Trading of Astera Labs

Several institutional investors and hedge funds have recently made changes to their positions in ALAB. Great Valley Advisor Group Inc. grew its stake in Astera Labs by 2.2% during the 2nd quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock worth $372,000 after buying an additional 90 shares during the last quarter. Straight Path Wealth Management boosted its holdings in shares of Astera Labs by 1.5% in the second quarter. Straight Path Wealth Management now owns 6,850 shares of the company’s stock valued at $619,000 after acquiring an additional 100 shares during the period. Rye Brook Capital LLC boosted its holdings in shares of Astera Labs by 1.1% in the third quarter. Rye Brook Capital LLC now owns 9,200 shares of the company’s stock valued at $1,801,000 after acquiring an additional 100 shares during the period. Assetmark Inc. grew its position in shares of Astera Labs by 374.1% during the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after acquiring an additional 101 shares during the last quarter. Finally, First Horizon Advisors Inc. increased its holdings in shares of Astera Labs by 12.4% in the 2nd quarter. First Horizon Advisors Inc. now owns 982 shares of the company’s stock valued at $89,000 after acquiring an additional 108 shares during the period. 60.47% of the stock is owned by hedge funds and other institutional investors.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.